npj Digital Medicine (Oct 2024)

Feasibility of snapshot testing using wearable sensors to detect cardiorespiratory illness (COVID infection in India)

  • Olivia K. Botonis,
  • Jonathan Mendley,
  • Shreya Aalla,
  • Nicole C. Veit,
  • Michael Fanton,
  • JongYoon Lee,
  • Vikrant Tripathi,
  • Venkatesh Pandi,
  • Akash Khobragade,
  • Sunil Chaudhary,
  • Amitav Chaudhuri,
  • Vaidyanathan Narayanan,
  • Shuai Xu,
  • Hyoyoung Jeong,
  • John A. Rogers,
  • Arun Jayaraman

DOI
https://doi.org/10.1038/s41746-024-01287-2
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 12

Abstract

Read online

Abstract The COVID-19 pandemic has challenged the current paradigm of clinical and community-based disease detection. We present a multimodal wearable sensor system paired with a two-minute, movement-based activity sequence that successfully captures a snapshot of physiological data (including cardiac, respiratory, temperature, and percent oxygen saturation). We conducted a large, multi-site trial of this technology across India from June 2021 to April 2022 amidst the COVID-19 pandemic (Clinical trial registry name: International Validation of Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms; NCT05334680; initial release: 04/15/2022). An Extreme Gradient Boosting algorithm was trained to discriminate between COVID-19 infected individuals (n = 295) and COVID-19 negative healthy controls (n = 172) and achieved an F1-Score of 0.80 (95% CI = [0.79, 0.81]). SHAP values were mapped to visualize feature importance and directionality, yielding engineered features from core temperature, cough, and lung sounds as highly important. The results demonstrated potential for data-driven wearable sensor technology for remote preliminary screening, highlighting a fundamental pivot from continuous to snapshot monitoring of cardiorespiratory illnesses.